Core Viewpoint - Tonghua Jinma's stock price has shown significant growth this year, with an increase of 82.23% year-to-date, indicating strong market performance and investor interest [1][2]. Financial Performance - For the period from January to September 2025, Tonghua Jinma reported operating revenue of 892 million yuan, a year-on-year decrease of 7.88%, while net profit attributable to shareholders was 24.96 million yuan, reflecting a year-on-year increase of 4.35% [2]. - The company has cumulatively distributed 210 million yuan in dividends since its A-share listing, with no dividends paid in the last three years [3]. Stock Market Activity - As of December 22, the stock price was 28.61 yuan per share, with a market capitalization of 27.651 billion yuan. The stock experienced a trading volume of 334 million yuan and a turnover rate of 1.23% [1]. - The stock has appeared on the "龙虎榜" (a list of stocks with significant trading activity) twice this year, with the most recent appearance on September 11, where it recorded a net buy of 142 million yuan [1]. Shareholder Structure - As of September 30, 2025, the number of shareholders was 38,200, a decrease of 3.20% from the previous period, with an average of 25,266 shares held per shareholder, an increase of 3.31% [2]. - The top ten circulating shareholders include notable entities such as Innovation Drug and Southern CSI 1000 ETF, with varying changes in their holdings compared to the previous period [3].
通化金马涨2.03%,成交额3.34亿元,主力资金净流入658.39万元